• Profile
Close

Ten-year treatment outcomes of radical prostatectomy vs external beam radiation therapy vs brachytherapy for 1,503 patients with intermediate risk prostate cancer

Urology Nov 19, 2019

Goy BW, et al. - A retrospective analysis using propensity score matching was carried out on 1,503 intermediate-risk prostate cancer (IRPC) individuals who underwent treatment from 2004 to 2007 in order to contrast 10-year oncologic treatment outcomes of radical prostatectomy (RP) vs external beam radiation therapy (EBRT) vs brachytherapy (BT) for individuals with IRPC. No notable variations in distant metastases-free survival (DMFS) or prostate cancer-specific survival (PCSS) was noted following adjusting for age and Charlson comorbidity index. Hence, for IRPC inidivduals, BT using Iodine-125, used alone or in combination with supplemental external radiation, is a flexible treatment alternative generating equivalent rates of DMFS and PCSS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay